Director Paul Rothman receives 733 RSUs at Labcorp (NYSE: LH)

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Paul Rothman reported an equity award in the form of Restricted Stock Units. On February 10, 2026, he acquired 733 Restricted Stock Units as a grant, each representing the right to receive one share of Labcorp common stock if vesting conditions are met.

These Restricted Stock Units vest fully on February 10, 2027. Following this grant, Rothman beneficially holds a total of 1,670 Restricted Stock Units in a direct ownership capacity, aligning his compensation more closely with the company’s future share performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rothman Paul

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/10/2026		A		733		(2)	(2)	Common Stock	733	$0	1,670(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on February 10, 2027.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Paul Rothman	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Labcorp (LH) director Paul Rothman report?

Labcorp director Paul Rothman reported receiving 733 Restricted Stock Units as an equity award. The grant was made on February 10, 2026 and represents additional stock-based compensation tied to Labcorp’s future share performance rather than an open-market stock purchase or sale.

How many Labcorp (LH) Restricted Stock Units does Paul Rothman now hold?

After the February 10, 2026 award, Paul Rothman beneficially owns 1,670 Restricted Stock Units. This total reflects the aggregate number of RSUs reported as directly held and links a portion of his compensation to Labcorp’s long-term stock value.

When do Paul Rothman’s new Labcorp (LH) Restricted Stock Units vest?

The newly granted 733 Restricted Stock Units vest fully on February 10, 2027. Vesting means Rothman will become entitled to receive one share of Labcorp common stock for each unit, assuming any applicable service or other vesting conditions are satisfied.

What does each Labcorp (LH) Restricted Stock Unit granted to Paul Rothman represent?

Each Restricted Stock Unit represents a contingent right to receive one share of Labcorp common stock. The units are not shares today, but convert into shares when vesting conditions are met, providing stock-based compensation aligned with the company’s performance over time.

Was Paul Rothman’s Labcorp (LH) transaction a stock purchase or sale?

The transaction was an acquisition of 733 Restricted Stock Units as a grant, not a market purchase or sale. It is classified as a grant, award, or other acquisition and reflects stock-based compensation rather than cash-funded trading activity in Labcorp shares.